Andrew J. Cutler, MD: The Value of Delayed Release ADHD Treatments
In an interview with HCPLive®, Andrew J. Cutler, MD, Clinical Professor of Psychiatry at SUNY Upstate Medical University, discussed the value of extended release medication and how it can aid patients in improving their quality of life. (video)
Other Articles in this Edition
ADHD Treatment Change Impacts Remote Patient Monitoring
Surveys Show Remote Behavioral Parent Training for ADHD is Acceptable Option
Novel SMS Strategy May Help Increase Stimulant Adherence in Adults with ADHD
Sleep Regularity, Timing Could Influence ADHD Symptoms in Teens
Andrew J. Cutler, MD: The Value of Delayed Release ADHD Treatments
David W. Goodman, MD: Silver Linings in ADHD
David W. Goodman, MD: Adult ADHD Challenges During COVID-19
ADHD Coaching an Emerging Tool for Patients
Postnatal Smoke Exposure Likely Significant Risk Factor for ADHD in Children
Comorbidities Related to Pediatric ADHD May Be Characterized Using CBCL